News Headlines Article

Avandia: When does a drug’s harm outweigh its benefit?
Los Angeles Times

It’s scary enough that a widely prescribed diabetes drug, Avandia, was shown in new studies this week to pose a substantially greater risk of heart attacks for users.

But what should really get consumers freaked is that healthcare experts and federal regulators say this isn’t really surprising. When it comes to drug safety, they say, you can’t make an omelet without breaking a few eggs.